HEADER OXIDOREDUCTASE 21-JUN-16 5KKA TITLE E. COLI MALATE DEHYDROGENASE WITH THE INHIBITOR 6DHNAD COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALATE DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.1.1.37; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI (STRAIN K12); SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: MDH, B3236, JW3205; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MALATE, DEHYDROGENASE, 6DHNAD, INHIBITOR, BETA- 6-DIHYDRONICOTIMIDE KEYWDS 2 ADENINE DINUCLEOTIDE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR K.M.MENEELY,A.L.LAMB,G.R.MORAN REVDAT 3 27-NOV-19 5KKA 1 REMARK REVDAT 2 13-SEP-17 5KKA 1 JRNL REMARK REVDAT 1 02-NOV-16 5KKA 0 JRNL AUTH B.A.BEAUPRE,J.V.ROMAN,M.R.HOAG,K.M.MENEELY,N.R.SILVAGGI, JRNL AUTH 2 A.L.LAMB,G.R.MORAN JRNL TITL LIGAND BINDING PHENOMENA THAT PERTAIN TO THE METABOLIC JRNL TITL 2 FUNCTION OF RENALASE. JRNL REF ARCH.BIOCHEM.BIOPHYS. V. 612 46 2016 JRNL REFN ESSN 1096-0384 JRNL PMID 27769837 JRNL DOI 10.1016/J.ABB.2016.10.011 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 58919 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.155 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.400 REMARK 3 FREE R VALUE TEST SET COUNT : 2001 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.4102 - 4.2122 0.99 4321 152 0.1550 0.1536 REMARK 3 2 4.2122 - 3.3439 0.99 4117 148 0.1434 0.1462 REMARK 3 3 3.3439 - 2.9213 0.99 4123 150 0.1586 0.1870 REMARK 3 4 2.9213 - 2.6543 1.00 4117 141 0.1567 0.1957 REMARK 3 5 2.6543 - 2.4641 0.99 4054 138 0.1468 0.1737 REMARK 3 6 2.4641 - 2.3188 0.99 4077 141 0.1443 0.1803 REMARK 3 7 2.3188 - 2.2027 0.99 4057 145 0.1419 0.1951 REMARK 3 8 2.2027 - 2.1068 1.00 4039 147 0.1466 0.1927 REMARK 3 9 2.1068 - 2.0257 0.99 4063 144 0.1505 0.1779 REMARK 3 10 2.0257 - 1.9558 0.99 4025 146 0.1630 0.1970 REMARK 3 11 1.9558 - 1.8947 0.99 4031 137 0.1677 0.2109 REMARK 3 12 1.8947 - 1.8405 0.99 4032 131 0.1791 0.2287 REMARK 3 13 1.8405 - 1.7921 0.99 3993 150 0.1807 0.2306 REMARK 3 14 1.7921 - 1.7483 0.95 3869 131 0.1929 0.2175 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.840 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 4532 REMARK 3 ANGLE : 1.103 6163 REMARK 3 CHIRALITY : 0.057 753 REMARK 3 PLANARITY : 0.007 787 REMARK 3 DIHEDRAL : 12.307 2707 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KKA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000222377. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SI(111) AND SI(220) DOUBLE REMARK 200 CRYSTAL REMARK 200 OPTICS : RH COATED FLAT, TOROIDAL REMARK 200 FOCUSING REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58987 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 39.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.54800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.10_2155 REMARK 200 STARTING MODEL: 3HHP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES, PH 6.0, 21% PEG 6,000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.76500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.63750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.91600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.63750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.76500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.91600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 79 REMARK 465 ALA A 80 REMARK 465 ARG A 81 REMARK 465 LYS A 82 REMARK 465 PRO A 83 REMARK 465 GLY A 84 REMARK 465 MET A 85 REMARK 465 ASP A 86 REMARK 465 ARG A 87 REMARK 465 SER A 88 REMARK 465 ASP A 89 REMARK 465 LYS A 312 REMARK 465 ALA B 80 REMARK 465 ARG B 81 REMARK 465 LYS B 82 REMARK 465 PRO B 83 REMARK 465 GLY B 84 REMARK 465 MET B 85 REMARK 465 ASP B 86 REMARK 465 ARG B 87 REMARK 465 SER B 88 REMARK 465 ASP B 89 REMARK 465 LYS B 312 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL B 79 O HOH B 501 1.99 REMARK 500 O HOH B 555 O HOH B 707 2.12 REMARK 500 O HOH A 639 O HOH A 737 2.14 REMARK 500 O HOH B 503 O HOH B 714 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 59 -158.84 -134.46 REMARK 500 THR A 224 -50.48 -126.41 REMARK 500 THR B 224 -56.39 -126.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6V0 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6V0 B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KKC RELATED DB: PDB DBREF 5KKA A 1 312 UNP P61889 MDH_ECOLI 1 312 DBREF 5KKA B 1 312 UNP P61889 MDH_ECOLI 1 312 SEQRES 1 A 312 MET LYS VAL ALA VAL LEU GLY ALA ALA GLY GLY ILE GLY SEQRES 2 A 312 GLN ALA LEU ALA LEU LEU LEU LYS THR GLN LEU PRO SER SEQRES 3 A 312 GLY SER GLU LEU SER LEU TYR ASP ILE ALA PRO VAL THR SEQRES 4 A 312 PRO GLY VAL ALA VAL ASP LEU SER HIS ILE PRO THR ALA SEQRES 5 A 312 VAL LYS ILE LYS GLY PHE SER GLY GLU ASP ALA THR PRO SEQRES 6 A 312 ALA LEU GLU GLY ALA ASP VAL VAL LEU ILE SER ALA GLY SEQRES 7 A 312 VAL ALA ARG LYS PRO GLY MET ASP ARG SER ASP LEU PHE SEQRES 8 A 312 ASN VAL ASN ALA GLY ILE VAL LYS ASN LEU VAL GLN GLN SEQRES 9 A 312 VAL ALA LYS THR CYS PRO LYS ALA CYS ILE GLY ILE ILE SEQRES 10 A 312 THR ASN PRO VAL ASN THR THR VAL ALA ILE ALA ALA GLU SEQRES 11 A 312 VAL LEU LYS LYS ALA GLY VAL TYR ASP LYS ASN LYS LEU SEQRES 12 A 312 PHE GLY VAL THR THR LEU ASP ILE ILE ARG SER ASN THR SEQRES 13 A 312 PHE VAL ALA GLU LEU LYS GLY LYS GLN PRO GLY GLU VAL SEQRES 14 A 312 GLU VAL PRO VAL ILE GLY GLY HIS SER GLY VAL THR ILE SEQRES 15 A 312 LEU PRO LEU LEU SER GLN VAL PRO GLY VAL SER PHE THR SEQRES 16 A 312 GLU GLN GLU VAL ALA ASP LEU THR LYS ARG ILE GLN ASN SEQRES 17 A 312 ALA GLY THR GLU VAL VAL GLU ALA LYS ALA GLY GLY GLY SEQRES 18 A 312 SER ALA THR LEU SER MET GLY GLN ALA ALA ALA ARG PHE SEQRES 19 A 312 GLY LEU SER LEU VAL ARG ALA LEU GLN GLY GLU GLN GLY SEQRES 20 A 312 VAL VAL GLU CYS ALA TYR VAL GLU GLY ASP GLY GLN TYR SEQRES 21 A 312 ALA ARG PHE PHE SER GLN PRO LEU LEU LEU GLY LYS ASN SEQRES 22 A 312 GLY VAL GLU GLU ARG LYS SER ILE GLY THR LEU SER ALA SEQRES 23 A 312 PHE GLU GLN ASN ALA LEU GLU GLY MET LEU ASP THR LEU SEQRES 24 A 312 LYS LYS ASP ILE ALA LEU GLY GLU GLU PHE VAL ASN LYS SEQRES 1 B 312 MET LYS VAL ALA VAL LEU GLY ALA ALA GLY GLY ILE GLY SEQRES 2 B 312 GLN ALA LEU ALA LEU LEU LEU LYS THR GLN LEU PRO SER SEQRES 3 B 312 GLY SER GLU LEU SER LEU TYR ASP ILE ALA PRO VAL THR SEQRES 4 B 312 PRO GLY VAL ALA VAL ASP LEU SER HIS ILE PRO THR ALA SEQRES 5 B 312 VAL LYS ILE LYS GLY PHE SER GLY GLU ASP ALA THR PRO SEQRES 6 B 312 ALA LEU GLU GLY ALA ASP VAL VAL LEU ILE SER ALA GLY SEQRES 7 B 312 VAL ALA ARG LYS PRO GLY MET ASP ARG SER ASP LEU PHE SEQRES 8 B 312 ASN VAL ASN ALA GLY ILE VAL LYS ASN LEU VAL GLN GLN SEQRES 9 B 312 VAL ALA LYS THR CYS PRO LYS ALA CYS ILE GLY ILE ILE SEQRES 10 B 312 THR ASN PRO VAL ASN THR THR VAL ALA ILE ALA ALA GLU SEQRES 11 B 312 VAL LEU LYS LYS ALA GLY VAL TYR ASP LYS ASN LYS LEU SEQRES 12 B 312 PHE GLY VAL THR THR LEU ASP ILE ILE ARG SER ASN THR SEQRES 13 B 312 PHE VAL ALA GLU LEU LYS GLY LYS GLN PRO GLY GLU VAL SEQRES 14 B 312 GLU VAL PRO VAL ILE GLY GLY HIS SER GLY VAL THR ILE SEQRES 15 B 312 LEU PRO LEU LEU SER GLN VAL PRO GLY VAL SER PHE THR SEQRES 16 B 312 GLU GLN GLU VAL ALA ASP LEU THR LYS ARG ILE GLN ASN SEQRES 17 B 312 ALA GLY THR GLU VAL VAL GLU ALA LYS ALA GLY GLY GLY SEQRES 18 B 312 SER ALA THR LEU SER MET GLY GLN ALA ALA ALA ARG PHE SEQRES 19 B 312 GLY LEU SER LEU VAL ARG ALA LEU GLN GLY GLU GLN GLY SEQRES 20 B 312 VAL VAL GLU CYS ALA TYR VAL GLU GLY ASP GLY GLN TYR SEQRES 21 B 312 ALA ARG PHE PHE SER GLN PRO LEU LEU LEU GLY LYS ASN SEQRES 22 B 312 GLY VAL GLU GLU ARG LYS SER ILE GLY THR LEU SER ALA SEQRES 23 B 312 PHE GLU GLN ASN ALA LEU GLU GLY MET LEU ASP THR LEU SEQRES 24 B 312 LYS LYS ASP ILE ALA LEU GLY GLU GLU PHE VAL ASN LYS HET 6V0 A 401 71 HET 6V0 B 401 71 HETNAM 6V0 [[(2~{R},3~{S},4~{R},5~{R})-5-(5-AMINOCARBONYL-2~{H}- HETNAM 2 6V0 PYRIDIN-1-YL)-3,4-BIS(OXIDANYL)OXOLAN-2-YL]METHOXY- HETNAM 3 6V0 OXIDANYL-PHOSPHORYL] [(2~{R},3~{S},4~{R},5~{R})-5-(6- HETNAM 4 6V0 AMINOPURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN-2-YL]METHYL HETNAM 5 6V0 HYDROGEN PHOSPHATE HETSYN 6V0 6DHNAD FORMUL 3 6V0 2(C21 H29 N7 O14 P2) FORMUL 5 HOH *473(H2 O) HELIX 1 AA1 GLY A 10 LEU A 24 1 15 HELIX 2 AA2 VAL A 38 HIS A 48 1 11 HELIX 3 AA3 ALA A 63 GLU A 68 1 6 HELIX 4 AA4 PHE A 91 CYS A 109 1 19 HELIX 5 AA5 PRO A 120 ALA A 135 1 16 HELIX 6 AA6 ASP A 139 ASN A 141 5 3 HELIX 7 AA7 THR A 147 GLY A 163 1 17 HELIX 8 AA8 GLN A 165 VAL A 169 5 5 HELIX 9 AA9 SER A 178 VAL A 180 5 3 HELIX 10 AB1 LEU A 186 VAL A 189 5 4 HELIX 11 AB2 THR A 195 ASN A 208 1 14 HELIX 12 AB3 ASN A 208 LYS A 217 1 10 HELIX 13 AB4 THR A 224 GLN A 243 1 20 HELIX 14 AB5 SER A 285 ASN A 311 1 27 HELIX 15 AB6 GLY B 10 LEU B 24 1 15 HELIX 16 AB7 VAL B 38 HIS B 48 1 11 HELIX 17 AB8 ALA B 63 GLU B 68 1 6 HELIX 18 AB9 PHE B 91 CYS B 109 1 19 HELIX 19 AC1 PRO B 120 ALA B 135 1 16 HELIX 20 AC2 THR B 147 GLY B 163 1 17 HELIX 21 AC3 GLN B 165 VAL B 169 5 5 HELIX 22 AC4 SER B 178 VAL B 180 5 3 HELIX 23 AC5 LEU B 186 VAL B 189 5 4 HELIX 24 AC6 THR B 195 ASN B 208 1 14 HELIX 25 AC7 ASN B 208 ALA B 218 1 11 HELIX 26 AC8 THR B 224 GLN B 243 1 20 HELIX 27 AC9 SER B 285 ASN B 311 1 27 SHEET 1 AA1 6 VAL A 53 PHE A 58 0 SHEET 2 AA1 6 SER A 28 TYR A 33 1 N LEU A 30 O LYS A 54 SHEET 3 AA1 6 LYS A 2 LEU A 6 1 N VAL A 5 O TYR A 33 SHEET 4 AA1 6 VAL A 72 ILE A 75 1 O LEU A 74 N ALA A 4 SHEET 5 AA1 6 CYS A 113 ILE A 116 1 O GLY A 115 N VAL A 73 SHEET 6 AA1 6 LEU A 143 GLY A 145 1 O PHE A 144 N ILE A 116 SHEET 1 AA2 2 VAL A 173 GLY A 175 0 SHEET 2 AA2 2 ILE A 182 PRO A 184 -1 O LEU A 183 N ILE A 174 SHEET 1 AA3 3 VAL A 249 GLU A 255 0 SHEET 2 AA3 3 PHE A 263 GLY A 271 -1 O PHE A 264 N VAL A 254 SHEET 3 AA3 3 GLY A 274 ARG A 278 -1 O GLY A 274 N GLY A 271 SHEET 1 AA4 6 VAL B 53 PHE B 58 0 SHEET 2 AA4 6 SER B 28 TYR B 33 1 N LEU B 30 O LYS B 54 SHEET 3 AA4 6 LYS B 2 LEU B 6 1 N VAL B 3 O GLU B 29 SHEET 4 AA4 6 VAL B 72 ILE B 75 1 O LEU B 74 N LEU B 6 SHEET 5 AA4 6 CYS B 113 ILE B 116 1 O GLY B 115 N VAL B 73 SHEET 6 AA4 6 LEU B 143 GLY B 145 1 O PHE B 144 N ILE B 116 SHEET 1 AA5 2 VAL B 173 GLY B 175 0 SHEET 2 AA5 2 ILE B 182 PRO B 184 -1 O LEU B 183 N ILE B 174 SHEET 1 AA6 3 VAL B 249 GLU B 255 0 SHEET 2 AA6 3 PHE B 263 GLY B 271 -1 O PHE B 264 N VAL B 254 SHEET 3 AA6 3 GLY B 274 ARG B 278 -1 O GLU B 276 N LEU B 269 CISPEP 1 ASN A 119 PRO A 120 0 -0.45 CISPEP 2 ASN B 119 PRO B 120 0 -0.10 SITE 1 AC1 30 ALA A 9 GLY A 10 GLY A 11 ILE A 12 SITE 2 AC1 30 TYR A 33 ASP A 34 ILE A 35 SER A 76 SITE 3 AC1 30 ALA A 77 GLY A 78 ASN A 94 ILE A 97 SITE 4 AC1 30 ASN A 100 LEU A 101 ILE A 117 ASN A 119 SITE 5 AC1 30 VAL A 121 VAL A 146 HIS A 177 ALA A 223 SITE 6 AC1 30 THR A 224 MET A 227 HOH A 509 HOH A 538 SITE 7 AC1 30 HOH A 548 HOH A 560 HOH A 589 HOH A 612 SITE 8 AC1 30 HOH A 625 HOH A 675 SITE 1 AC2 30 GLY B 7 GLY B 10 GLY B 11 ILE B 12 SITE 2 AC2 30 TYR B 33 ASP B 34 ILE B 35 SER B 76 SITE 3 AC2 30 ALA B 77 GLY B 78 ILE B 97 ASN B 100 SITE 4 AC2 30 LEU B 101 ILE B 117 ASN B 119 VAL B 121 SITE 5 AC2 30 VAL B 146 HIS B 177 ALA B 223 THR B 224 SITE 6 AC2 30 MET B 227 HOH B 518 HOH B 532 HOH B 538 SITE 7 AC2 30 HOH B 553 HOH B 569 HOH B 575 HOH B 594 SITE 8 AC2 30 HOH B 605 HOH B 653 CRYST1 77.530 83.832 89.275 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012898 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011929 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011201 0.00000 MASTER 282 0 2 27 22 0 16 6 0 0 0 48 END